REGENXBIO Inc.

Bank of New York Mellon Corp RGNX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

145,594

Value ($000)

2,097

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	2,097	0.0%	145,594	12/31/2025
2025 Q3	11/3/2025	1,449	0.0%	150,133	9/30/2025
2025 Q2	8/5/2025	1,183	0.0%	144,110	6/30/2025
2025 Q1	4/29/2025	1,011	0.0%	141,400	3/31/2025
2024 Q4	2/4/2025	1,246	0.0%	161,136	12/31/2024
2024 Q3	11/12/2024	3,361	0.0%	320,389	9/30/2024
2024 Q2	7/25/2024	3,972	0.0%	339,514	6/30/2024
2024 Q1	4/25/2024	6,546	0.0%	310,668	3/31/2024
2023 Q4	1/29/2024	6,063	0.0%	337,773	12/31/2023
2023 Q3	10/24/2023	5,937	0.0%	360,696	9/30/2023
2023 Q2	8/3/2023	7,335	0.0%	366,958	6/30/2023
2023 Q1	5/9/2023	6,711	0.0%	354,883	3/31/2023
2022 Q4	2/14/2023	8,141	0.0%	358,957	12/31/2022
2022 Q3	11/14/2022	8,988	0.0%	340,056	9/30/2022
2022 Q2	8/15/2022	8,284	0.0%	335,361	6/30/2022
2022 Q1	5/11/2022	11,440	0.0%	344,671	3/31/2022
2021 Q4	2/11/2022	11,241	0.0%	343,750	12/31/2021
2021 Q3	11/18/2021	14,206	0.0%	338,873	9/30/2021
2021 Q2	8/11/2021	12,432	0.0%	320,004	6/30/2021
2021 Q1	5/13/2021	11,910	0.0%	349,133	3/31/2021
2020 Q4	2/9/2021	14,276	0.0%	314,731	12/31/2020
2020 Q3	11/12/2020	8,887	0.0%	322,916	9/30/2020
2020 Q2	8/12/2020	12,829	0.0%	348,359	6/30/2020
2020 Q1	5/6/2020	11,311	0.0%	349,338	3/31/2020
2019 Q4	2/14/2020	14,365	0.0%	350,616	12/31/2019